Karthik Jagadeesh is the Co-Founder and CDO of TenSixty Biosciences, an AI bioscience company in order to revolutionize the treatment of cancer using cell models and machine learning. Their mission is to create a map of antibody targets on cancer cells. Jagadeesh is also a Berkley alumnus with a PhD in CS at Stanford University.